Dr. Lorna Rodriguez Named Director of GYN/Oncology at Cancer Center
September 24, 1996
Lorna Rodriguez, M.D., Ph.D., an oncology surgeon and gene therapy researcher, has been appointed director of the Division of GYN/Oncology at the University of Rochester School of Medicine and Dentistry. She holds a dual academic appointment as Associate Professor of Oncology in Obstetrics/Gynecology and in Microbiology and Immunology.
As a researcher, Dr. Rodriguez has worked with immunologist Dr. Susan Horowitz, who did the original studies on the mechanisms of the cancer drug, Taxol. She brings to Rochester a coveted NIH Physician Scientist Award.
Dr. Rodriguez comes to the post from Albert Einstein Medical School in the Bronx, where she was assistant professor of medicine.
A graduate of the University of Puerto Rico Medical School, Dr. Rodriguez completed a fellowship in GYN/Oncology at the University of Michigan, and a Ph.D. in biochemistry from the University of Rochester. As a graduate student at the UR School of Medicine and Dentistry, she won the Bloor Award for best doctoral thesis in biochemistry.
Dr. Rodriguez' research interests are in the field of gene therapy for ovarian cancer.